Journal of The Electrochemical Society,
Journal Year:
2024,
Volume and Issue:
171(9), P. 097509 - 097509
Published: Sept. 2, 2024
Bilirubin
(BR)
is
a
yellow-to-orange
bile
pigment
produced
by
hemoglobin
breakdown.
It
circulates
in
the
blood,
absorbed
liver,
and
then
conjugated
to
form
bilirubin
diglucuronide.
Its
increased
level
serum
(Hyperbilirubinemia)
may
considered
as
an
indication
of
certain
diseases
such
neonatal
jaundice,
hepatitis,
severe
liver
failure
with
cirrhosis.
Thus,
monitoring
BR
plasma
clinically
important.
Herein,
novel
carbon/chitosan
paste
electrode
modified
L-leucine
Albumin
(C/Chi-PL-BSA)
synthesized
tested
for
electrochemical
sensitive
determination
Uric
Acid.
Significate
sensitivity
important
selectivity
linear
range
1.00–150.00
μM
BR,
10.00–600.00
UA
were
obtained.
Moreover,
micromolar
detection
limits
0.40
1.00
achieved
at
pH13.
The
proposed
oxidation
mechanisms
alkaline
media
have
been
supported
DFT
calculations
B3LYP/
6–31
G(d)
theory.
easy
preparation
high
reproducibility
made
this
very
appropriate
pharmaceutical
preparations
BR.
Furthermore,
Analyses
using
human
performed,
demonstrating
percentage
recovery.
Luminescence,
Journal Year:
2025,
Volume and Issue:
40(1)
Published: Jan. 1, 2025
ABSTRACT
Based
on
nitrogen
and
phosphorus
co‐doped
carbon
dots
(NP‐CDs),
a
direct,
quick,
selective
sensing
probe
for
fluorometric
detection
of
rutin
has
been
developed.
Utilizing
ethylene
diamine
tetra
acetic
acid
(EDTA)
as
source
diammonium
hydrogen
phosphate
(NH
4
)
2
HPO
source.
The
NP‐CDs
were
synthesized
in
less
than
3
min
with
straightforward
one‐step
microwave
pyrolysis
process
high
quantum
yield
(63.8%).
After
being
excited
at
λ
=
360
nm,
the
produced
displayed
maximum
bluish
fluorescence
em
420
nm.
Rutin
quenched
based
inner
filter
effect
static
quenching
processes.
Along
International
Council
Harmonization
(ICH)
requirements,
developed
spectrofluorometric
method
was
validated.
linearity
range
0.50–35.00
μg/mL
rutin.
successfully
employed
to
determine
concentrations
marketed
tablets.
is
simple,
consistent,
sensitive,
selective,
it
does
not
require
expensive
chemicals
or
specialized
instruments.
This
study
paves
path
future
application
NP‐CD
pharmaceutical
analysis.
Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 3, 2025
Abstract
This
review
underscores
the
transformative
potential
of
photonic
nanomaterials
in
wearable
health
technologies,
driven
by
increasing
demands
for
personalized
monitoring.
Their
unique
optical
and
physical
properties
enable
rapid,
precise,
sensitive
real‐time
monitoring,
outperforming
conventional
electrical‐based
sensors.
Integrated
into
ultra‐thin,
flexible,
stretchable
formats,
these
materials
enhance
compatibility
with
human
body,
enabling
prolonged
wear,
improved
efficiency,
reduced
power
consumption.
A
comprehensive
exploration
is
provided
integration
devices,
addressing
material
selection,
light‐matter
interaction
principles,
device
assembly
strategies.
The
highlights
critical
elements
such
as
form
factors,
sensing
modalities,
data
communication,
representative
examples
skin
patches
contact
lenses.
These
devices
precise
monitoring
management
biomarkers
diseases
or
biological
responses.
Furthermore,
advancements
approaches
have
paved
way
continuum
care
systems
combining
multifunctional
sensors
therapeutic
drug
delivery
mechanisms.
To
overcome
existing
barriers,
this
outlines
strategies
design,
engineering,
system
integration,
machine
learning
to
inspire
innovation
accelerate
adoption
next‐generation
health,
showcasing
their
versatility
digital
applications.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 17, 2024
Field-effect
transistor
(FET)
biosensors
based
on
nanomaterials
are
promising
in
the
areas
of
food
safety
and
early
disease
diagnosis
due
to
their
ultrahigh
sensitivity
rapid
response.
However,
most
academically
developed
FET
lack
real-world
reproducibility
comprehensive
methodological
validation
meet
standards
regulatory
bodies.
Here,
highly
uniform
well-packaged
semiconducting
carbon
nanotube
(CNT)
biosensor
chips
were
assessed
for
plug-and-play
sensing
sensitive
detection
aflatoxin
B1
(AFB1)
real
samples
international
standards.
In
order
requirements
stability,
a
scalable
residual-free
passivation
packaging
process
was
CNT
biosensors.
Portable
systems
then
constructed
on-site
detection.
The
resulting
packaged
functionalized
with
nucleic
aptamers
enable
selective
AFB1
limit
(LOD)
0.55
fg/mL
(standard)
cross-reactivity
coefficients
interferences
as
low
1.8
×
10
Journal of Agricultural and Food Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 11, 2025
Acrylamide
(AM)
is
a
recognized
carcinogen
and
neurotoxin,
posing
significant
threat
to
food
safety
human
health.
Therefore,
developing
sensitive
convenient
methods
for
AM
detection
in
samples
essential.
This
study
responds
the
urgent
need
selective
of
AM,
hidden
hazard
food,
safeguard
public
health
environmental
safety.
We
present
development
novel
two-dimensional
ultrasound-synthesized
PVP-Gd
composite
nanosheet
platform
precise
sensing.
These
self-assembled
nanosheets,
constructed
from
gadolinium
(Gd)
poly(vinylpyrrolidone)
(PVP),
exhibit
remarkable
stability
robust
blue
fluorescence,
with
quantum
yield
45.01%
upon
excitation
at
380
nm.
A
full
factorial
design
was
employed
optimize
synthesis
process,
revealing
parameter
interactions.
The
optimized
nanosheets
demonstrated
strong
quenching
effect
acrylamide
exposure,
resulting
high-performance
sensor
an
impressively
low
limit
(9.4
nM)
broad
linear
response
range.
innovative
offers
promising
approach
monitoring
applications,
effectively
addressing
risks
associated
acrylamide.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 2846 - 2846
Published: March 21, 2025
Green
carbon
dots
(GCDs)
have
emerged
as
a
revolutionary
tool
in
precision
medicine,
offering
transformative
capabilities
for
personalized
diagnostics
and
therapeutic
strategies.
Their
unique
optical
biocompatible
properties
make
them
ideal
non-invasive
imaging,
real-time
monitoring,
integration
with
genomics,
proteomics,
bioinformatics,
enabling
accurate
diagnosis
tailored
treatments
based
on
patients’
genetic
molecular
profiles.
This
study
explores
the
potential
of
GCDs
advancing
individualized
patient
care
by
examining
their
applications
medicine.
It
evaluates
utility
diagnostic
targeted
therapy
delivery,
formulation
treatment
plans,
emphasizing
interaction
advanced
genomic,
proteomic,
bioinformatics
platforms.
demonstrated
exceptional
versatility
precise
delivering
therapies.
cutting-edge
technologies
showed
significant
promise
crafting
strategies,
enhancing
functionality
effectiveness
monitoring
patient-specific
applications.
The
findings
underscore
pivotal
role
reshaping
healthcare
medicine
improving
outcomes.
ongoing
development
emerging
to
further
enhance
capabilities,
paving
way
more
effective,
medical
care.
RSC Advances,
Journal Year:
2025,
Volume and Issue:
15(12), P. 8855 - 8866
Published: Jan. 1, 2025
A
sensitive
“turn-off”
fluorescent
method
using
MPA-CdTe
quantum
dots
was
developed
for
the
selective
determination
of
lurasidone
in
pharmaceutical
formulations,
spiked
plasma,
and
environmental
water
samples.